Skip to search formSkip to main contentSkip to account menu

fenofibric acid

Known as: 2-(4-(4'-chlorophenoxy)phenoxy)propionic acid, 2-(4-(4-chlorophenoxy)phenoxy)propanoic acid, Propanoic Acid, 2-(4-(4-Chlorobenzoyl)Phenoxy)-2-Methyl- 
The active form of fenofibrate, a synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
No clinical benefit from modulating high triglyceride levels and low high-density–lipoprotein cholesterol levels with fibrates… 
Highly Cited
2001
Highly Cited
2001
The proposed mechanism for the triglyceride (TG) lowering by fibrate drugs is via activation of the peroxisome proliferator… 
Highly Cited
1998
Highly Cited
1998
Fibrates are widely used hypolipidemic drugs which activate the nuclear peroxisome proliferator-activated receptor (PPAR) α and… 
Highly Cited
1997
Highly Cited
1997
Intracellular fatty acid (FA) concentrations are in part determined by a regulated import/export system that is controlled by two… 
Highly Cited
1996
Highly Cited
1996
Increased activity of lipoprotein lipase (LPL) may explain the hypotriglyceridemic effects of fibrates, thiazolidinediones and… 
Highly Cited
1995
Highly Cited
1995
In view of the evidence linking plasma high density lipoprotein (HDL)-cholesterol levels to a protective effect against coronary… 
Highly Cited
1995
Highly Cited
1995
The long-chain acyl-coenzyme A synthetase (ACS) gene gives rise to three transcripts containing different first exons preceded by… 
Review
1990
Review
1990
Fenofibrate is a lipid-regulating drug which is structurally related to other fibric acid derivatives, such as clofibrate. At the…